| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122212 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/08/2006 | US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 06/08/2006 | US20060122192 Chemical compounds |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121132 TNF-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/08/2006 | US20060121094 Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals |
| 06/08/2006 | US20060121079 Delivering a dose of gold, silver or an alloy of particles having a cross-sectional diameter of >20 mu m and the same weight but a greater surface area than that of solid spheres; direct contact with tissue to release ions for uptake by macrophages without phagocytosis of particles; immunocompetence |
| 06/08/2006 | US20060121056 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | DE102004057595A1 Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen Substituted pteridines for the treatment of inflammatory diseases |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2588980A1 Vasopressin-binding l-nucleic acid |
| 06/08/2006 | CA2586774A1 Treatment of inflammation |
| 06/08/2006 | CA2586114A1 Process for {3-[2(r)-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-triazol-1-yl}phosphonic acid |
| 06/07/2006 | EP1666606A1 Method for detecting regulatory effect on controlling synoviolin activity |
| 06/07/2006 | EP1666498A2 Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof |
| 06/07/2006 | EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666465A1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor |
| 06/07/2006 | EP1666092A2 Drug combination comprising a fatty acid and a uridine compound. |
| 06/07/2006 | EP1666065A1 Therapeutic agent for autoimmune disease |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1666045A1 Sphingomyelin containing preparation for the enhancement of tumor therapy and for the treatment of rheumatoid arthritis |
| 06/07/2006 | EP1666039A1 Use of L-alpha-lysophosphatidylcholine inhibitors to prevent inflammation |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664027A1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
| 06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
| 06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
| 06/07/2006 | EP1663993A1 Guanidine derivatives |
| 06/07/2006 | EP1663979A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| 06/07/2006 | EP1663974A1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
| 06/07/2006 | EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 06/07/2006 | EP1663970A1 Matrix metalloproteinase inhibitors |
| 06/07/2006 | EP1663966A1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/07/2006 | EP1663398A1 Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline reuptake inhibitors |
| 06/07/2006 | EP1663268A1 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 06/07/2006 | EP1663244A2 Pteridine derivatives for the treatment of septic shock and tnf-alpha-related diseases. |
| 06/07/2006 | EP1663238A1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
| 06/07/2006 | EP1663224A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug |
| 06/07/2006 | EP1663181A2 Protein binding compounds |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1434787A4 Lp mammalian proteins; related reagents |
| 06/07/2006 | EP1427723B1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
| 06/07/2006 | EP1411899A4 Taste masking composition |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1265630B1 Use of insulin for the treatment of cartilagenous disorders |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1148783B1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 06/07/2006 | EP1095059B1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 06/07/2006 | EP1071463B1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | CN1784410A Protein kinase inhibitors |
| 06/07/2006 | CN1784403A Azaindole compounds as kinase inhibitors |
| 06/07/2006 | CN1784387A Benzimidazole derivatives |
| 06/07/2006 | CN1784386A 1,2-diarylimidazoles useful as inhibitors of COX |
| 06/07/2006 | CN1784219A Ultraviolet-shielding type patch |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/07/2006 | CN1781543A Ant oil liniment and its preparing method |
| 06/07/2006 | CN1781540A Medicinal pad for treating rheumatoid disease |
| 06/07/2006 | CN1781532A Plaster for removing obstruction in channels and relieving pain |
| 06/07/2006 | CN1781527A Xingnaoling magic plaster |
| 06/07/2006 | CN1781520A Method for preparing Qingkailing preparation |
| 06/07/2006 | CN1781519A New medicine for treating appendicitis |
| 06/07/2006 | CN1781509A Composition of luffa seed oil |
| 06/07/2006 | CN1781506A American ginseng and royal jelly soft capsule |
| 06/07/2006 | CN1781500A Use of red yeast in preparing anti-inflammatory medicine |
| 06/07/2006 | CN1258551C Preparing method of degradable polymer |
| 06/07/2006 | CN1258376C Plaster for treating hyperosteogeny |
| 06/07/2006 | CN1258373C Medicine for treating lumbosacral pain and its preparing method |
| 06/07/2006 | CN1258368C Medicine for curing hyperthermia and its preparing method |
| 06/07/2006 | CN1258360C Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7057049 Mitogen-activated protein kinase inhibitors |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056928 anti-inflammatory, anti-pyretic and analgesic properties, without the potential side effects associated with inhibition of COX-1 |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056914 Benzoxazinone-derived compounds, their preparation and use as medicaments |